JPX · 3544.T
Satudora Holdings Co.,Ltd.
¥1,246-¥1 (-0.08%)
Satudora Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
Loading market information…
JPX · 7702.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
JMS Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
JMS Co.,Ltd.’s forward annual dividend is ¥17 per share, paid semi-annual. The forward yield is 3.91% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
JMS Co.,Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow JMS Co.,Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
JMS Co., Ltd., established in 1947 and headquartered in Hiroshima, Japan, specializes in the development, manufacture, distribution, and global trade of a wide array of medical devices and pharmaceuticals. Its extensive product catalog serves both Japanese and international markets, addressing diverse medical needs. The company provides a comprehensive range of items for infusion and transfusion therapy, including infusion/transfusion sets (some featuring needle-free access ports), single-use needles and syringes, secure scalp vein sets, safe intravenous catheters, extension tubing, oral and enteral feeding systems, infusion and syringe delivery pumps, devices for administering semi-solid nutritional supplements, as well as blood bags, blood collection scales and mixers, high-frequency tube sealing equipment, and serum collection apparatus. For general medical use, JMS offers essential consumables for healthcare institutions such as surgical and examination gloves (both latex and plastic), treatment drapes, surgical gowns, protective masks and caps, drainage receptacles, and surgical adhesive tapes. Furthermore, JMS is a key supplier for hemodialysis and peritoneal dialysis, providing centralized dialysate delivery systems, hemodialysis units, AV fistula needles, systems designed to prevent accidental needlestick injuries, blood tubing sets for hemodialysis, dialyzers, pre-filled syringes, complete hemodialysis kits, single-patient dialysis devices, dialysis solutions for Continuous Ambulatory Peritoneal Dialysis (CAPD), and automated peritoneal dialysis equipment. The company also offers specialized products for cardiovascular therapy, which encompass cardiopulmonary support systems, membrane oxygenators, heat exchange units, pacemakers, microcatheters, and blood tubing sets for cardiopulmonary bypass.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,246-¥1 (-0.08%)
Satudora Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
¥2,812-¥9 (-0.32%)
Sakurasaku Plus Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.06% below the high.
¥418+¥2 (+0.48%)
Daiken Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.52% below the high.
¥1,498-¥4 (-0.27%)
WOLVES HAND Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 48.34% below the high.
¥303+¥3 (+1.0%)
Wakamoto Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 20.26% below the high.
¥1,950+¥1 (+0.05%)
J Frontier Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.92% below the high.
¥585-¥2 (-0.34%)
GENOVA, Inc.’s quoted price sits in the lower half of its reported 52-week range, 13.33% below the high.
¥1,443-¥44 (-2.96%)
JTEC Corporation’s quoted price sits in the lower half of its reported 52-week range, 42.6% below the high.
